4.3 Article

Suppression of EAE by oral tolerance is independent of endogenous IFN-β whereas treatment with recombinant IFN-β ameliorates EAE

Related references

Note: Only part of the references are listed.
Article Immunology

It takes guts for tolerance: The phenomenon of oral tolerance and the regulation of autoimmune response

Jean Pierre Schatzmann Peron et al.

AUTOIMMUNITY REVIEWS (2009)

Review Clinical Neurology

Interferon-β treatment for multiple sclerosis

Robert A. Bermel et al.

NEUROTHERAPEUTICS (2007)

Article Gastroenterology & Hepatology

Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferonβ 1a

Eckart Schott et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2007)

Article Immunology

CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation

Driss Ehirchiou et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2007)

Article Immunology

Immunomodulatory dendritic cells in intestinal lamina propria

FG Chirdo et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2005)

Review Pharmacology & Pharmacy

The changing face of cytokines in the brain: Perspectives from EAE

RD Wheeler et al.

CURRENT PHARMACEUTICAL DESIGN (2005)

Article Immunology

Activation of CD25+CD4+ regulatory T cells by oral antigen administration

XM Zhang et al.

JOURNAL OF IMMUNOLOGY (2001)

Review Immunology

Oral tolerance

P Garside et al.

SEMINARS IN IMMUNOLOGY (2001)